AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

RecruitingPhase 2Ages 18 Years - 75 YearsAllAtom Therapeutics Co., Ltd
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in participants with ASCVD. The primary efficacy measurement will be assessed at 52W of treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Unless otherwise specified, subjects must meet all of the following criteria at screening: * Diagnosed with coronary at herosclerosis, and coronary angiography. * Male or female at 18-75 years of age (inclusive). * Weight โ‰ฅ40 kg. * Currently using any oral lipid-lowering therapy. * Able to understand and willing to sign an ICF and comply with study requirements. * A woman or man of childbearing potential agreeing to use medically approved contraceptive methods from the screening until 3 months after the last study dose. Exclusion Criteria: Unless otherwise specified, subjects are excluded from the study if any of the following criteria is met: * History of stroke within the past 6 months. * Uncontrolled arrhythmia within 3 months prior to screening. * Evidence of any active or suspected cancer within 3 years prior to the screening. * Having undergone any major surgery within 3 months prior to the screening or planning to undergo any major surgery during the study. * Presence or suspicion of ongoing of any serious infection. * Human immunodeficiency virus (HIV) infection.
๐Ÿ’Š

What it tests

  • ABP-745 Dose A
  • Placebo
  • ABP-745 Dose B
  • ABP-745 Dose C
๐Ÿ“

Where

33 sites
Cardiovascular Research Foundation of Southern California
Beverly Hills, United States
Cardiovascular Institute of San Diego INC
San Diego, United States
The Lundquist Institute
Torrance, United States
Washington University School of Medicine, St.louis
St Louis, United States
NovaTrails
Newcastle, Australia
University of the Sunshine Coast Clinical Trials Unit - Morayfield
Morayfield, Australia
Core Research Group Pty Ltd
Brisbane, Australia
UniSC Clinical Trials (Brisbane)
Brisbane, Australia

โ€ฆand 25 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy